Helixgate https://validator.w3.org/feed/docs/rss2.html Home The State of Biotech 2026 Human iPSC-Derived Heart Assembloids Reproduce Valve Development and Disease STAT+: Trump is counting on the health care industry to remake vaccines. They’re pushing back instead Bispecific Antibody Purification’s Complexity Problem and How to Fix It How we know that splitting up the MMR vaccine could be dangerous FDA rejects ITM Isotope’s radiopharma therapy over manufacturing issues Indiana Emerges as a Leading U.S. Biopharma Hub Chasing Dupixent, a biotech aims to make better antibody drugs for eczema Scholar Rock rejigs approval filing after FDA flags violations at Novo plant How South Carolina Became the Southeast’s Fastest Growing Biotech Hub After billions in deals, Insilico CEO promises: ‘You haven’t seen anything yet’ Epicrispr, Infinimmune snag combined $165M in VC cash Epicrispr lands $90M to advance epigenetic editing drug for rare muscle disease AbCellera’s menopause medicine ‘sets new efficacy bar’ for hot flashes Silence causes uproar in rare blood cancer space as data sets high bar for competitors Vaderis hauls in $152M to test an AKT-targeting drug STAT+: Nurses seek a seat at the table as they fight expanding clinical AI Austria’s new growth fund could further bolster its dynamic biotech innovation economy BMS Chooses Houston for $2.3B Manufacturing Facility Bacterial Trait-Finding and Gene Mapping Platform Speeds Microbial Engineering for Biotech Applications Trump returns to controversial vaccine policy with order questioning childhood schedule Candida auris Persists in Hair Follicles, Hijacks Immune Signaling BMS picks Texas for new $2.3B manufacturing campus Sionna cystic fibrosis drug fails key trial, removing threat to Vertex BaseMap ABE Launched for Off-Target Characterization in Base Editing Therapeutic Development Base editing to enable single-base genomic changes STAT+: In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment Sionna’s cystic fibrosis failure is a windfall for Vertex’s blockbuster franchise AstraZeneca partners with CSPC to build Chinese biologics manufacturing plant STAT+: Pharmalittle: We’re reading about a Sanofi drug shortage, a Jazz Pharma deal, and more Tenax shares nosedive as heart failure drug fails in Phase 3 STAT+: Sionna’s experimental cystic fibrosis pill falls flat in mid-stage trial BlossomHill, Latigo bloom on Nasdaq with oversubscribed IPOs Early-Life Stress Leaves Epigenetic “Scars” That Prime Stress Sensitivity Potatoes may have given Indigenous Andeans a digestive superpower BioMarin axes asset from $270M Inozyme takeover, ending run in rare metabolic indication ITM neuroendocrine tumor drug spurned by FDA over manufacturing qualms Denali climbs past Avlayah expectations with $3.6M in revenue STAT+: A shortage of two Sanofi medicines for Pompe disease rattles patients Scientists discover bacteria that lock toxic uranium into a stable form Regulatory operations: The overlooked half of submission readiness From ex vivo to in vivo: Shaping the next generation of viral vector manufacturing StockWatch: Lilly Rises on Revenue Leap; Analysts High on Krystal Despite Revenue Miss Biogen’s targeted ALS treatment is reversing decline in some patients. Can more be helped? As BMS’ Cobenfy struggles to gain traction, MapLight knocks on the door Author Correction: Reprogramming yeast metabolism for customized starch-rich micro-grain through low-carbon microbial manufacturing Author Correction: Precise integration of large DNA sequences in plant genomes using PrimeRoot editors Opinion: Fauci doesn’t have the answers on Covid’s origins. China does Novel Molecular Glue Discovery Platform Unlocks Undruggable Cancer Targets